Results 101 to 110 of about 2,937,657 (199)

Stability and turbulence in illegal drug markets. [PDF]

Proc Natl Acad Sci U S A
Kilmer B.
europepmc   +1 more source

Organizational Scope and Investment: Evidence from the Drug Development Strategies and Performance of Biopharmaceutical Firms [PDF]

This paper compares the clinical trial strategies and performance of large, established ("mature") biopharmaceutical firms to those of smaller ("early stage") firms that have not yet successfully developed a drug.
Ilan Guedj, David Scharfstein
core  

The Detection of Novel Nitazene-Class Opioids in Unregulated Drug Markets in Canada. [PDF]

Drug Alcohol Rev
Gelgoot EA, Scarfone KM, Maghsoudi N, McDonald K, Hao W, Stefan C, Beriault DR, Delaney SR, Ti L, Tobias S, Bowles JM, Werb D, Members of Toronto's Drug Checking Service.   +12 more
europepmc   +1 more source

Ohio BWC Drug-Free EZ Program : technical assistance manual : reference/resource guide

, 2002
Title from title screen (viewed Sept. 24, 2004).; "BWC-7648 (Rev. 7/18/2002)"--Screen 87 (i.e. p. 1 of form: Progress report, Drug-Free Workplace/Drug-Free EZ Program).; Electronic text (pdf, 89 p.).; Harvested from the web on 9/24 ...
Drug-Free EZ Program (Ohio. Bureau of Workers' Compensation)
core  

Preclinical pharmacology of N-pyrrolidino "nitazene" opioids appearing in nonmedical drug markets. [PDF]

J Pharmacol Exp Ther
Glatfelter GC, Maitland AD, Gonzalez NR, Walther D, Chen L, Shi L, Baumann MH.   +6 more
europepmc   +1 more source

Drug markets - price making analysis

, 2011
The thesis deals with economic theory and research of the drug markets. Analysis of the literature compares individual approaches to theories by present authors, including their conclusions on data for the U.S.
Rössl, Karel
core  

A Scoping Review of the Emergence of Novel Synthetic Opioids in Australian Drug Markets: What Does This Mean for Harm Reduction Responses? [PDF]

Drug Alcohol Rev
Mammoliti E, Nielsen S, Roxburgh A.
europepmc   +1 more source

Australian Trends in Ecstasy and Related Drug Markets 2007: Findings from the Ecstasy and Related Drugs Reporting System (EDRS)

, 2008
The Australian Drug Trends in Ecstasy and Related Drug Markets 2007 report presents the findings from the fifth year in which data have been collected in all states and territories in Australia on the markets for ecstasy and related drugs (ERDs).
Campbell, Gabrielle, Quinn, Brendan, White, Nancy, George, Jessica, Kinner, Stuart, Degenhardt, Louisa, Black, Emma, Dunn, Matthew, Matthews, Allison, Urbancic-Kenny, Ana, Roxburgh, Amanda   +10 more
core  

Reinforcing effects of fentanyl analogs found in illicit drug markets. [PDF]

Psychopharmacology (Berl)
Maitland AD, McGriff SA, Glatfelter GC, Schindler CW, Baumann MH.   +4 more
europepmc   +1 more source

An ethnographic exploration of drug markets in Kisumu, Kenya. [PDF]

Int J Drug Policy, 2016
Syvertsen JL, Ohaga S, Agot K, Dimova M, Guise A, Rhodes T, Wagner KD.   +6 more
europepmc   +1 more source